Related Experiment Video

Updated: Jul 20, 2026

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection
05:55

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection

Published on: May 7, 2020

Drug Insight: adjunctive therapies in adults with bacterial meningitis

Diederik van de Beek1, Martijn Weisfelt, Jan de Gans

  • 1Academic Medical Center, Center of Infection and Immunity Amsterdam, University of Amsterdam, The Netherlands. d.vandebeek@amc.uva.nl

Nature Clinical Practice. Neurology
|August 26, 2006
PubMed

Insights

Bacterial meningitis remains deadly despite antibiotics. This review examines adjunctive therapies, like dexamethasone, to improve outcomes for bacterial meningitis patients by reducing inflammation and complications.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Pharmacology

Background:

  • Bacterial meningitis has high mortality and morbidity despite antibiotic availability.
  • Antibiotic-induced bacterial lysis can cause subarachnoid space inflammation, potentially worsening outcomes.
  • Management is complex, with complications including meningoencephalitis, systemic compromise, stroke, and raised intracranial pressure.

Purpose of the Study:

  • To review the pathogenesis and pathophysiology of bacterial meningitis.
  • To evaluate the evidence for and against adjunctive therapies in adult bacterial meningitis.
  • To summarize current clinical practice and research on improving patient outcomes.

Main Methods:

  • Literature review of pathogenesis, pathophysiology, and clinical studies.
  • Focus on adjunctive therapies such as anti-inflammatory agents, anticoagulants, and intracranial pressure reduction strategies.
  • Analysis of evidence from randomized clinical trials and other studies.

Main Results:

  • Dexamethasone has shown promise in a recent randomized trial.
  • Limited randomized clinical studies exist for other adjunctive therapies in adults.
  • Evidence synthesis on the efficacy and risks of various supportive treatments.

Conclusions:

  • Adjunctive therapies are crucial for managing bacterial meningitis complications.
  • Further high-quality clinical trials are needed to establish the role of most adjunctive therapies.
  • Optimizing treatment strategies may reduce mortality and morbidity in bacterial meningitis.

More Related Videos

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

Related Concept Videos

Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...